ABIOMED, Inc. May 22 announced that the French regulatory agency for medical devices, the Agence Française de Sécurité Sanitaire des Produits de Santé (AFSSAPS) has granted approval of the AB5000 Circulatory Support System. France represents one of the largest medical device markets in Europe. All of ABIOMED's Circulatory Support Systems including the IMPELLA products are now available in France, providing French patients in acute heart failure with access to life-saving circulatory support. In addition, ABIOMED announced plans to open an office in Paris to provide French customers with direct customer service, and sales and clinical expertise as they incorporate Ventricular Assist Device (VAD) Recovery Programs into standard clinical practice. Abiomed (http://www.abiomed.com/news/ab5k_france_approval.cfm)
Simplifying Global Compliance
Recommended Products
GMP Inspection Preparation Checklist: A Tool for Internal Auditing
This management report includes more than 650 items organized in three sections covering all aspects of quality manufacturing.
Biological Risk Evaluation and Management for Medical Devices
Report shows how the FDA incorporates the two ISO standards in its medical device development policy, how the EU version of the two standards differs in significant ways and how the EU Medical Device Regulation may require further changes in the European standards.
Editor's Picks
Matrix Surgical’s OmniPore Implants Cleared for Marketing
The company expects to launch additional variants in early 2019.
AbbVie, Novartis Reach Deal on Humira Biosimilar
AbbVie reported Humira sales of $18.4 billion in 2017.